Skip to main content

Rita Jain, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Anaptysbio, Inc publishes a filing, an earnings call transcript or a press release.

Get ANAB alerts

About Rita Jain, M.D.

Rita Jain, M.D. is recorded as Board Member at Anaptysbio, Inc (ANAB) since April 3, 2023. Anaptysbio, Inc reported in an 8-K filed April 6, 2023 that Rita Jain, M.D. was appointed Class II director, effective April 3, 2023. Anaptysbio, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anaptysbio, Inc includes Daniel Faga (CEO and Board Member), John Orwin (Chairman and Board Member), Ajim Tamboli (CFO) and 7 others.

“On April 3, 2023, the Board appointed Rita Jain, M.D. as a Class II director and as a member of the Compensation Committee, effective immediately.”
Anaptysbio, Inc Form 8-K, filed April 6, 2023 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2023-04-03–present

Leadership on record at Anaptysbio, Inc

Recent activity